This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 600+ CE and professional development courses.

Get access starting at $49.95/yrLoading..

Goals and Learning Outcomes

Healthcare professionals have an important role in opening discussions with patients and their family members regarding advance care planning. Despite intensive efforts, most Americans do not have an advance directive and may face a life-threatening illness without a plan to guide their healthcare providers or relatives. End-of-life care experts stress the need for major changes in the approach to promoting advance care planning, including a focus on promoting ongoing dialogue between patients and healthcare providers. As patient advocates, clinicians are in a strong position to work with patients and other healthcare professionals to make these important changes occur.

The goal of this course is to provide healthcare professionals with information regarding ways to improve conversations about advance care planning such as advance directives and living wills.

This course has a maximum of 3 exam attempts.


After taking this course, you should be able to:

  • Identify barriers that patients, families and healthcare professionals face in implementing Advance Directives
  • Describe problems created by lack of an Advance Directive
  • Describe new ways that healthcare professionals can involve patients in advance care planning
  • Identify barriers that patients, families and healthcare professionals face in implementing discussions regarding advance care planning such as advance directives and living wills.
  • Recall what advance care planning entails.
  • Identify barriers that patients, families, and healthcare professionals face in implementing advance care planning.
  • Indicate ways that healthcare professionals can involve patients in advance care planning.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/25

Course Originally Released On: 06/01/22

Course Authors

4.3 Average

Course Reviews

18905 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.